Compare · PLTR vs TDOC
PLTR vs TDOC
Side-by-side comparison of Palantir Technologies Inc. (PLTR) and Teladoc Health Inc. (TDOC): market cap, price performance, sector, and recent activity on the wire.
Summary
- PLTR operates in Technology, while TDOC operates in Health Care - the two are in different parts of the market.
- PLTR is the larger of the two at $25.48B, about 19.8x TDOC ($1.29B).
- Over the past year, PLTR is down 4.1% and TDOC is up 4.3% - TDOC leads by 8.4 points.
- TDOC has been more active in the news (8 items in the past 4 weeks vs 6 for PLTR).
- Both have 25 recent analyst ratings on file.
- Company
- Palantir Technologies Inc.
- Teladoc Health Inc.
- Price
- $175.22+1.88%
- $7.07-0.77%
- Market cap
- $25.48B
- $1.29B
- 1M return
- +38.24%
- -23.81%
- 1Y return
- -4.11%
- +4.28%
- Industry
- Computer Software: Prepackaged Software
- Medical/Nursing Services
- Exchange
- NYSE
- NYSE
- IPO
- 2015
- News (4w)
- 6
- 8
- Recent ratings
- 25
- 25
Palantir Technologies Inc.
Palantir Technologies Inc. builds and deploys software platforms for the intelligence community in the United States to assist in counterterrorism investigations and operations. The company provides Palantir Gotham, a software platform for government operatives in the defense and intelligence sectors, which enables users to identify patterns hidden deep within datasets, ranging from signals intelligence sources to reports from confidential informants, as well as facilitates the handoff between analysts and operational users, helping operators plan and execute real-world responses to threats that have been identified within the platform. It also offers Palantir Foundry, a platform that transforms the ways organizations operate by creating a central operating system for their data; and allows individual users to integrate and analyze the data they need in one place. Palantir Technologies Inc. was founded in 2003 and is headquartered in Denver, Colorado.
Teladoc Health Inc.
Teladoc Health, Inc. provides virtual healthcare services on a business-to-business basis in the United States and internationally. It covers various clinical conditions, including non-critical, episodic care, chronic, and complicated cases like cancer and congestive heart failure, as well as offers telehealth solutions, chronic condition management, expert medical services, behavioral health solutions, guidance and support, and platform and program services. It serves health employers, health plans, hospitals, health systems, and insurance and financial services companies. The company offers its products and services under the Teladoc, Livongo, Advance Medical, Best Doctors, BetterHelp, and HealthiestYou brands. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. Teladoc Health, Inc. was Incorporated in 2002 and is headquartered in Purchase, New York.
Latest PLTR
- Officer Sankar Shyam converted options into 35,000 shares and sold $5,449,544 worth of shares (35,000 units at $155.70) as part of a pre-agreed trading plan (SEC Form 4)
- Director Stat Lauren Elaina Friedman sold $500,280 worth of shares (3,032 units at $165.00) as part of a pre-agreed trading plan, decreasing direct ownership by 5% to 54,107 units (SEC Form 4)
- Palantir Technologies upgraded by Deutsche Bank with a new price target
- Palantir Technologies Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits
- Palantir Reports Q2 2026 U.S. Comm Revenue Growth of 149% Y/Y and Revenue Growth of 93% Y/Y; Raises FY 2026 Revenue Guidance to 82% Y/Y Growth and U.S. Comm Revenue Guidance to 134% Y/Y, Crushing Consensus Expectations
- SEC Form 4 filed by Officer Buckley Jeffrey
- Director Moore Alexander D. sold $2,144,770 worth of shares (16,000 units at $134.05) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 1,095,095 units (SEC Form 4)
- Palantir Announces Date of Second Quarter 2026 Earnings Release and Webcast
- Rackspace Technology Launches Operating Framework with Palantir for Regulated Enterprises to Accelerate Enterprise AI in Production
- Officer Sankar Shyam converted options into 35,000 shares and sold $24,050,000 worth of shares (185,000 units at $130.00) as part of a pre-agreed trading plan (SEC Form 4)
Latest TDOC
- SEC Form 4 filed by Director Anquillare Mark V
- SEC Form 3 filed by new insider Anquillare Mark V
- Teladoc Health Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits
- Teladoc Health Appoints Financial Executive Mark Anquillare to Its Board of Directors
- SEC Form 10-Q filed by Teladoc Health Inc.
- Teladoc Health Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Teladoc Health Reports Second Quarter 2026 Results
- Teladoc Health introduces a virtual care practice built around the person, shaping a new era of connected care
- Teladoc Health to Announce Second Quarter 2026 Financial Results
- President, U.S. Group Health Bliss Kelly sold $23,750 worth of shares (2,500 units at $9.50) as part of a pre-agreed trading plan, decreasing direct ownership by 3% to 84,878 units (SEC Form 4)